Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP98
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,176
Award facts
- Contract value 100% obligated
- $47,176.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 2, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $47,176.27 to DMS Pharmaceutical Group Inc. for the supply of Keytruda 100 mg/4 mL vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will deliver this oncology medication to support military healthcare facility needs. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, with performance taking place in Park Ridge, Illinois. No set-aside designation was applied to this award.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.9 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare systems. The IDC arrangement allows DLA to issue multiple firm fixed-price delivery orders for branded and generic prescription drugs, biologics, and specialty medications as needed to support military medical operations. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain through its consistent performance on similar delivery orders covering diverse pharmaceutical categories.
Quick answers
Who was awarded contract SPE2DB25FYP98?
SPE2DB25FYP98 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FYP98 worth?
The government has obligated $47,176 on SPE2DB25FYP98.
Is contract SPE2DB25FYP98 an order under another contract?
Yes. SPE2DB25FYP98 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP98 competed?
The extent of competition for SPE2DB25FYP98 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award